World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
85
Citations
30015
World Ranking
14499
National Ranking
7334

Overview

Neil H. Bander is affiliated with Cornell University in the United States and has contributed extensively to medical research, particularly in the field of prostate cancer treatment and imaging. Their work intersects several areas within medicine, including radiology, nuclear medicine, oncology, and pulmonary and respiratory medicine.

The range of their research topics includes:

  • Prostate Cancer Treatment and Research
  • Radiopharmaceutical Chemistry and Applications
  • Medical Imaging Techniques and Applications
  • Mass Spectrometry Techniques and Applications
  • Cancer Immunotherapy and Biomarkers
  • Prostate Cancer Diagnosis and Treatment
  • Peptidase Inhibition and Analysis

Neil H. Bander has published articles in several scientific venues, frequently contributing to:

  • Journal of Clinical Oncology
  • The Prostate
  • Annals of Oncology
  • Cancer Research
  • The Journal of Urology

Some of their recent research papers include:

  • "Reversible epigenetic alterations mediate PSMA expression heterogeneity in advanced metastatic prostate cancer" (2023) published in JCI Insight
  • "Prostate-Specific Membrane Antigen-Targeting Alpha Emitter via Antibody Delivery for Metastatic Castration-Resistant Prostate Cancer: A Phase I Dose-Escalation Study of 225Ac-J591" (2023) published in Journal of Clinical Oncology
  • "A simple strategy to reduce the salivary gland and kidney uptake of PSMA-targeting small molecule radiopharmaceuticals" (2021) published in European Journal of Nuclear Medicine and Molecular Imaging
  • "Phase I trial of docetaxel plus lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 (177Lu-J591) for metastatic castration-resistant prostate cancer" (2020) published in Urologic Oncology Seminars and Original Investigations
  • "Prostate-Specific Membrane Antigen Uptake and Survival in Metastatic Castration-Resistant Prostate Cancer" (2021) published in Frontiers in Oncology

Frequent co-authors who have collaborated with Neil H. Bander include:

  • Scott T. Tagawa
  • Joseph R. Osborne
  • David M. Nanus
  • Ana M. Molina
  • Cora N. Sternberg

The main fields of study that encompass Neil H. Bander's research are:

  • Medicine

Their subfields of interest include:

  • Radiology, Nuclear Medicine and Imaging
  • Pulmonary and Respiratory Medicine
  • Oncology
  • Spectroscopy
  • Cancer Research

Best Publications

  • Renal-cell carcinoma.

    Robert J. Motzer;Neil H. Bander;David M. Nanus

  • Mutations of the VHL tumour suppressor gene in renal carcinoma

    J.R. Gnarra;K. Tory;Y. Weng;L. Schmidt

  • Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile

    Jeffrey Hrkach;Daniel Von Hoff;Mir Mukkaram Ali;Elizaveta Andrianova

  • Five Different Anti-Prostate-specific Membrane Antigen (PSMA) Antibodies Confirm PSMA Expression in Tumor-associated Neovasculature

    Sam S. Chang;Victor E. Reuter;W. D. W. Heston;Neil H. Bander

  • Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse.

    Cora N. Sternberg;Alan Yagoda;Howard I. Scher;Robin C. Watson

  • Monoclonal Antibodies to the Extracellular Domain of Prostate-specific Membrane Antigen Also React with Tumor Vascular Endothelium

    He Liu;Peggy Moy;Sae Kim;Yan Xia

  • Tumor Therapy with Targeted Atomic Nanogenerators

    Michael R. McDevitt;Dangshe Ma;Lawrence T. Lai;Jim Simon

  • The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer

    Dimple Chakravarty;Andrea Sboner;Sujit S. Nair;Eugenia Giannopoulou

  • Phase I Trial of 177Lutetium-Labeled J591, a Monoclonal Antibody to Prostate-Specific Membrane Antigen, in Patients With Androgen-Independent Prostate Cancer

    Neil H. Bander;Matthew Ivan Milowsky;David M. Nanus;Lale Kostakoglu

  • M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced transitional cell carcinoma of the urothelium.

    Cora N. Sternberg;Cora N. Sternberg;Alan Yagoda;Alan Yagoda;Howard I. Scher;Howard I. Scher;Robin C. Watson;Robin C. Watson

  • Constitutive and antibody-induced internalization of prostate-specific membrane antigen

    He Liu;Ayyoppan K. Rajasekaran;Peggy Moy;Yan Xia

  • Identification of a cDNA encoding a parathyroid hormone-like peptide from a human tumor associated with humoral hypercalcemia of malignancy

    M Mangin;A C Webb;B E Dreyer;J T Posillico

  • Capture of circulating tumor cells from whole blood of prostate cancer patients using geometrically enhanced differential immunocapture (GEDI) and a prostate-specific antibody.

    Jason P. Gleghorn;Erica D. Pratt;Denise Denning;He Liu

  • Taxane-Induced Blockade to Nuclear Accumulation of the Androgen Receptor Predicts Clinical Responses in Metastatic Prostate Cancer

    Medha S Darshan;Matthew S Loftus;Maria Thadani-Mulero;Ben P Levy

  • Phase II study of Lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 for metastatic castration-resistant prostate cancer

    Scott T. Tagawa;Matthew I. Milowsky;Michael Morris;Shankar Vallabhajosula

  • 89Zr-DFO-J591 for ImmunoPET of Prostate-Specific Membrane Antigen Expression In Vivo

    Jason P. Holland;Vadim Divilov;Neil H. Bander;Peter M. Smith-Jones

  • Cancer Patient T Cells Genetically Targeted to Prostate-Specific Membrane Antigen Specifically Lyse Prostate Cancer Cells and Release Cytokines in Response to Prostate-Specific Membrane Antigen

    Michael C. Gong;Jean Baptiste Latouche;Anja Krause;Warren D W Heston

  • Superparamagnetic Iron Oxide Nanoparticle-Aptamer Bioconjugates for Combined Prostate Cancer Imaging and Therapy

    Andrew Z. Wang;Andrew Z. Wang;Vaishali Bagalkot;Christophoros C. Vasilliou;Frank Gu

  • Synthesis and in vitro testing of J591 antibody-dendrimer conjugates for targeted prostate cancer therapy.

    Anil K. Patri;Andrzej Myc;James Beals;Thommey P. Thomas

  • Phase I Trial of Yttrium-90--Labeled Anti--Prostate-Specific Membrane Antigen Monoclonal Antibody J591 for Androgen-Independent Prostate Cancer

    Matthew I. Milowsky;David M. Nanus;Lale Kostakoglu;Shankar Vallabhajosula

Frequent Co-Authors

David M. Nanus
David M. Nanus Cornell University
Stanley J. Goldsmith
Stanley J. Goldsmith Cornell University
Paul J. Christos
Paul J. Christos Cornell University
Himisha Beltran
Himisha Beltran Harvard University
Steven M. Larson
Steven M. Larson Memorial Sloan Kettering Cancer Center
Michael J. Morris
Michael J. Morris Memorial Sloan Kettering Cancer Center
Jason S. Lewis
Jason S. Lewis Memorial Sloan Kettering Cancer Center
Warren D.W. Heston
Warren D.W. Heston Case Western Reserve University
Cora N. Sternberg
Cora N. Sternberg Cornell University
John W. Babich
John W. Babich Cornell University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring career pathways related to medicine provides students with additional flexibility and specialization opportunities. Many aspiring medical professionals may consider a support or leadership role in healthcare, and pursuing an online healthcare administration degree can open doors to hospital and clinic management positions. These programs offer foundational knowledge in business, policy, and healthcare systems.

For those looking to advance into higher leadership roles or specialized administration, enrolling in one of the cheapest online mha programs is a popular pathway. Completing a master’s degree in healthcare administration helps professionals qualify for executive positions and drive organizational change.

If your interests are in clinical practice, consider the cheapest bsn to dnp programs, which allow registered nurses to achieve a high level of clinical expertise and leadership in advanced nursing practice. Alternatively, future pharmacists can benefit from pursuing accredited online pharmacist programs to gain advanced clinical skills and qualify for licensure.

Whether your goal is in leadership, nursing, or pharmacy, these online degree options support a variety of rewarding career paths in the healthcare sector.

Best Scientists Citing Neil H. Bander

Trending Scientists